Medicine & TechnologyRecent research analyzing blood donation samples since July 2020 shows that as of May 2021, 4 out of 5 American adults over the age of 16 have developed antibodies via infection or vaccine.
A UK study found that mixing different brands of COVID-19 vaccines, specifically mRNA vaccines from AstraZeneca and Pfizer could give better protection that could last for several years.
A team of experts from UCLA has discovered an immunotherapy solution against melanoma and tumors. MAOIs found in anti-depressants strengthen the immune system to fight back cancer cells.
Researchers at Washington University School of Medicine found that mild cases of COVID-19 still have immune cells in their bodies pumping out antibodies against the virus months after recovering.
A recent analysis showed LAVs or live-attenuated vaccines like those injected for measles, tuberculosis and polio may be potential for immunity to COVID-19.
The University of Oxford has launched a study that reinfects recovered COVID-19 patients to test what kind of immune response they have to help design tests that predict a person's immunity.
A Singaporean study suggests that more newborns have detectable levels of COVID-19 antibodies, but doctors are unsure yet of the type of protection it has and how long it will last.
A Russian scientist who infected himself with coronavirus for a second time to study the effectiveness of antibodies says hopes for herd immunity are overblown.
Imperial College London conducted the largest antibody study involving more than 360,000 people. The results give insight into immunity and the possibility of reinfection.
Thus far, there had only been a handful of coronavirus reinfections reported around the world. However, the cases raise many questions about the immune system's response to the virus and how long immunity lasts.
Coconut oil is recognized by Ayurveda for over 4,000 years as a healthy oil because of its antimicrobial properties and helping modulate a person's immunity.
A recent study says that although antibodies from a previous coronavirus infection might only last a short while, protection could still be possible. Experts point out that antibodies are only a small part of the equation and that people shouldn't be discouraged from developing a vaccine for COVID-19.
A new study reveals that immunity to COVID-19 could only last a few months. Findings from the research uncovered that in just two months, some coronavirus-recovered patients lose protection from the virus and are susceptible to getting reinfected once again.
Professor Sarah Gilbert, who leads Oxford University's trial for its coronavirus vaccine candidate, says their jab could provide long-term immunity, which could last for several years. Furthermore, she says it could even give off antibodies three times more than a person who recovered from COVID-19.